(NASDAQ:DKNG) is an online sports entertainment and gaming company based in Boston. (NASDAQ: DKNG )ĪRK Investment Management's Stake Value: $844,489,000ĪRK Investment Management's 13F Portfolio: 2.02%ĭraftKings Inc. The total worth of these stakes is $230 million. The analyst set a $13 price target for the biotech stock.Īs of the end of the second quarter, 19 hedge funds tracked by Insider Monkey reported owning stakes in Quantum-Si incorporated (NASDAQ:QSI). Mikson believes that Quantum-Si's low-cost genome sequencing platform will appeal to the global biopharmaceutical market. Kyle Mikson of Canaccord Genuity initiated a Buy rating on Quantum-Si incorporated (NASDAQ:QSI) on October 20.
ARK Investment Management owned 12.6 million shares of Quantum-Si incorporated (NASDAQ:QSI) at the end of the September quarter. According to Q3 filings, Cathie Wood upped her stake in the biotech stock by 214%. Quantum-Si incorporated (NASDAQ:QSI) is a biotech company that manufactures protein sequencing platforms. Quantum-Si incorporated (NASDAQ: QSI )ĪRK Investment Management's Stake Value: $105,904,000ĪRK Investment Management's 13F Portfolio: 0.25% Of the 873 elite funds tracked by Insider Monkey, 14 were bullish on TuSimple Holdings Inc. (NASDAQ:TSP) with a price target of $55 per share on November 4. RBC Capital kept an Outperform rating on TuSimple Holdings Inc. Year to date, the company received 6,875 truck orders. The company posted revenue of $1.8 million in the third quarter, topping estimates of $1.65 million. The autonomous tech company went public in April and the stock has returned over 15% in the past six months. (NASDAQ:TSP) worth $382 million at the end of the September quarter. The hedge fund owned over 10.3 million shares of TuSimple Holdings Inc. In the third quarter of 2021, ARK Investment Management increased its stake in the autonomous company by 60%. (NASDAQ:TSP) is a California-based self-driving truck company. (NASDAQ: TSP )ĪRK Investment Management's Stake Value: $382,967,000ĪRK Investment Management's 13F Portfolio: 0.91% (NYSE:SGFY) is one of the stocks Cathie Wood is buying in the third quarter. (NYSE:PATH), Invitae Corporation (NYSE:NVTA), Palantir Technologies Inc. (NYSE:SGFY), compared to 28 in the previous quarter worth $189 million. The analyst set a price target of $31 for the stock on November 15.Īt the end of the second quarter of 2021, 13 hedge funds in the database of Insider Monkey held stakes worth $167 million in Signify Health, Inc. (NYSE:SGFY) after the company posted strong Q3 results. Deutsche Bank analyst George Hill kept a Buy rating on Signify Health, Inc. The company recently reported its Q3 2021 where revenue jumped 29% from Q3 2020 to $199.2 million. (NYSE: PATH ), Invitae Corporation (NYSE: NVTA ), Palantir Technologies Inc.
Meanwhile, some of the stocks Cathie Wood is buying in the third quarter include UiPath Inc. (NASDAQ:TSLA) remains the largest holding of ARK Investment Management as of the end of the September quarter. (NASDAQ:TSLA) shares in the previous three months, as of early November. In 2020, Wood's flagship fund, ARK Innovation ETF (ARKK) returned over 152%.Ĭathie Wood recently rebalanced ARK's portfolio by selling approximately $1.3 billion worth of Tesla, Inc. Wood is known for investing in genomics, self-driving cars, fintech, and artificial intelligence. Wood is the CEO and founder of the $42 billion disruptive technology hedge fund ARK Investment Management.
If you want to skip our detailed analysis of these stocks, go directly to Cathie Wood is Buying These 5 Stocks. In this article, we discuss Cathie Wood is Buying These 10 Stocks.